SciTransfer
Organization

SFAX UNIVERSITY

Tunisian university bridging European research with North Africa in social sciences, epilepsy genomics, and microbiome studies.

University research groupsocietyTNNo active H2020 projects
H2020 projects
5
As coordinator
3
Total EC funding
€1.2M
Unique partners
37
What they do

Their core work

Sfax University is a Tunisian higher education institution with two distinct research strengths: social sciences addressing radicalization, governance, and cultural heritage in North Africa, and biomedical research focused on epilepsy genetics and the human microbiome. They serve as a key bridge between European research networks and the MENA region, frequently coordinating capacity-building projects that strengthen research infrastructure in Tunisia. Their work spans from community resilience against violent extremism to advanced genomic diagnostics for neurological disorders.

Core expertise

What they specialise in

Radicalization and violent extremism researchprimary
2 projects

DARE studied deradicalisation across youth and gender dimensions, while PAVE addressed violent extremism and community resilience in the Balkans and MENA.

Cultural heritage and governance in North Africaprimary
1 project

SfaxForward (coordinator) focused on cultural heritage in South Tunisia through interdisciplinary and participatory approaches, linking heritage to governance and migration.

Epilepsy genetics and clinical neurosciencesecondary
1 project

SEED project (coordinator) built diagnostic capacity for epileptic encephalopathies using next-generation sequencing and bioinformatics at Sfax University.

Human microbiome and genomic health sciencesemerging
1 project

MICAfrica (coordinator) aimed to establish a North African Consortium of the Human Microbiome, covering cancer, diabetes, and high-throughput sequencing.

Evolution & trajectory

How they've shifted over time

Early focus
Radicalization and social inclusion
Recent focus
Biomedical genomics and diagnostics

Sfax University entered H2020 in 2017 through social sciences — radicalization, inequality, and cultural heritage in the Tunisian transition context. From 2019 onward, they expanded significantly into biomedical research, coordinating projects on epilepsy genetics (SEED) and the human microbiome (MICAfrica), while maintaining their social sciences work through PAVE. This shift signals a deliberate institutional strategy to build hard-science research capacity alongside their established social sciences base.

Sfax University is pivoting toward genomics and biomedical research infrastructure, making them increasingly relevant for health-science collaborations targeting North Africa.

Collaboration profile

How they like to work

Role: consortium_leaderReach: Global21 countries collaborated

Sfax University leads more often than it follows — coordinating 3 out of 5 projects, all of which are Widening Participation actions designed to strengthen their own institutional capacity. Their 37 partners across 21 countries indicate a broad, hub-style network rather than a tight cluster of repeat collaborators. This pattern suggests they are effective at attracting European partners for capacity-building but are still developing long-term bilateral research relationships.

Sfax University has worked with 37 unique partners across 21 countries, reflecting a wide but relatively shallow network typical of Widening Participation beneficiaries building their first major European research connections.

Why partner with them

What sets them apart

Sfax University is one of the few Tunisian institutions active as a coordinator in H2020, giving them direct experience managing EU-funded projects — a rare asset in the MENA region. Their dual expertise in social sciences (radicalization, governance) and biomedical genomics is unusual and positions them as a versatile partner for interdisciplinary consortia. For any project needing a credible North African partner with EU project management experience, they are a strong candidate.

Notable projects

Highlights from their portfolio

  • SEED
    Largest single grant (EUR 351K) and coordinator role — built genomic diagnostics capacity for epileptic encephalopathies, a significant biomedical infrastructure investment.
  • MICAfrica
    Ambitious coordinator-led effort to create a North African Human Microbiome Consortium, positioning Sfax as a regional hub for microbiome research.
  • DARE
    Multi-country study on radicalization and equality that established Sfax University's credentials in sensitive social science research across Europe and MENA.
Cross-sector capabilities
healthsecurityenvironment
Analysis note: Profile based on 5 projects spanning 2017-2023. The dual social-sciences and biomedical profile is clearly supported by the data, but with only 1-2 projects per expertise area, the depth of each capability is hard to assess. The Widening Participation focus (3 of 5 projects) means much of their activity is capacity-building rather than frontier research, which prospective partners should factor into expectations.